The development of an investigational product requires precision, regulatory compliance, and efficiency to ensure the success of clinical trials. From early-stage development to large-scale clinical manufacturing, pharmaceutical and biotech companies rely on specialized investigational product Contract Development and Manufacturing Organizations (investigational product CDMOs) to fulfill regulatory requirements and accelerate time to market.
How to Choose an Investigational Product CDMO
Selecting the right investigational product CDMO is key to a smooth clinical trial progression. Look for a partner with expertise in Good Manufacturing Practice (GMP) compliance, flexible production capabilities, and experience in managing Investigational Medicinal Products (IMPs) across multiple therapeutic areas.
A robust clinical manufacturing CDMO should offer comprehensive end-to-end support, including formulation development, small-batch manufacturing, clinical packaging, and regulatory consulting. Scalability is also essential to ensure a seamless transition from early-phase trials to commercial production.
Key Services Offered by Clinical Manufacturing CDMOs
Optimizing dosage forms through Formulation and Process Development: Investigational product CDMOs possess expertise in optimizing formulations for investigational products across diverse dosage forms.
Supplying phase-specific trials with GMP Clinical Manufacturing: Small-scale production for Phase I–III trials with strict regulatory compliance and quality assurance.
Securing study integrity via Packaging and Labeling: Clinical trial supply packaging, randomization, and blinding to meet study requirements.
Navigating global filings with Regulatory Support: Clinical manufacturing CDMOs provide assistance with Investigational New Drug (IND) applications, Clinical Trial Applications (CTAs), and global regulatory compliance.
Assuring drug consistency via Analytics and Stability Testing: Comprehensive quality control testing to ensure product consistency and safety.
Advantages of Partnering with Clinical CDMOs
Ensuring compliance standards with Regulatory Compliance: Investigational product CDMOs ensure adherence to EMA, FDA, and other international regulatory standards for clinical manufacturing.
Adapting batch volumes via Flexible and Scalable Production: Clinical CDMOs have the capacity to manage small clinical batches with a seamless scale-up toward commercial manufacturing.
Utilizing high-containment suites in Advanced Facilities: State-of-the-art technology for aseptic processing, high-containment manufacturing, and specialized pharmaceutical formulations.
Accelerating trial timelines for Speed to Market: Streamlined processes to minimize delays and support efficient clinical trial execution.
Streamlining development workflows through End-to-End Support: From formulation development to final packaging, clinical manufacturing CDMOs offer complete solutions for investigational product success.
Investigational Product CDMO Companies
Some of the top investigational product CDMO companies include:
HIPRA BIOTECH SERVICES: Comprehensive capabilities spanning from cell line development to commercial manufacturing. [See CDMO profile]
Skyepharma: Specialists in the development and supply of oral technologies for the pharmaceutical, biotech, and consumer health industries. [See CDMO profile]
Ophtapharm, a Sentiss Company: Ophthalmic and otic production (solutions, suspensions, emulsions, ointments, and gels) in FDA-approved facilities for investigational products. [See CDMO profile]
CARBOGEN AMCIS: Development of highly potent APIs and small-scale cGMP manufacturing, featuring chromatography and lyophilization capabilities. [See CDMO profile]
Sichuan Huiyu Pharmaceuticals Co., Ltd: Manufacturing and formulation facilities supported by a core R&D center for the development of APIs, finished dosage forms, and investigational products. [See CDMO profile]
AdhexPharma SAS: CDMO specialized in transdermal patches and oromucosal films. [See CDMO profile]
Sylentis: Manufacturing of oligonucleotides for therapeutic applications. [See CDMO profile]
Apeloa Pharmaceutical Co., Ltd: Development and manufacturing services for APIs, intermediates, and registered starting materials. [See CDMO profile]
Glatt Pharmaceutical Services GmbH Co. & KG: cGMP CDMO providing comprehensive services in complex solid oral formulations. [See CDMO profile]
Lukas Heil-Betriebsstätte: High-performance plant for sterile and aseptic production, specializing in glass ampoules and investigational products. [See CDMO profile]
Darnytsia Kyiv: CMO featuring advanced facilities, rigorous quality controls, and expert teams for reliable, compliant solutions. [See CDMO profile]
Basic Pharma Manufacturing: Analytical services and regulatory support tailored to specific needs, adhering to all applicable quality guidelines. [See CDMO profile]
Adragos Pharma: Over a century of experience offering customer-centric pharmaceutical manufacturing and support for investigational products. [See CDMO profile]
Cellex Cell Professionals: Advanced Therapy (CGT) CDMO with a cell manufacturing plant and biological material collection center for investigational products. [See CDMO profile]
Rodon Biologics: Development of biopharmaceutical products for third parties, including batches for preclinical and clinical studies. [See CDMO profile]
White Raven: GMP facility dedicated to the aseptic fill & finish of sterile injectables and investigational products. [See CDMO profile]
BAG Health Care: Parenteral manufacturing (fill-finish) of vials in small and medium batches, including investigational products. [See CDMO profile]
Cambrex: Early-stage small molecule drug development within integrated drug substance and finished product facilities. [See CDMO profile]
Actylis Eugene: Discovery, development, cGMP, and commercial manufacturing of chemical processes. [See CDMO profile]
Aenova Group: Center of excellence for conventional solids, clinical services, and investigational products. [See CDMO profile]
HISTOCELL S.L: Development and manufacturing of cell therapies (iPSCs, MSCs, exosomes, secretomes) as well as medical devices and dermocosmetics. [See CDMO profile]
53Biologics Production Plant: Production of biologics from DNA to proteins, covering preclinical phases through cGMP manufacturing. [See CDMO profile]
Liof Pharma: Clinical CDMO specialized in aseptic manufacturing and lyophilization of biologics and injectables. [See CDMO profile]
Cultiply: CDMO for recombinant proteins, enzymes, DNA, and other bioderived products. [See CDMO profile]
BDI biotech: R&D partner in strain and bioprocess development, scale-up, and batch production. [See CDMO profile]
Cenexi: Clinical CDMO specialized in highly potent sterile injectables, particularly oncology. [See CDMO profile]
I+Med: Development and manufacturing of dosage forms with controlled release technologies. [See CDMO profile]
ASCIL Biopharm: GMP facility equipped for R&D and pharmaceutical development with a pilot plant for technical and clinical batches of sterile products. [See CDMO profile]
VIVUNT: Clinical CDMO for investigational sterile oncology drugs. [See CDMO profile]
Grifols: Clinical manufacturing of bags and vials for multiple applications. [See CDMO profile]
Lannett CDMO: Primary manufacturing site in Seymour, Indiana, offering capabilities for oral solids and liquid forms. [See CDMO profile]
Viswa: CRAMS/CDMO for APIs, intermediates, and specialty chemicals. [See CDMO profile]
FAES FARMA: Development and manufacturing of investigational products for human use. [See CDMO profile]
Pharmaron: Commercial facility for small molecules (RSM/APIs). [See CDMO profile]
Shilpa Biologicals: End-to-end CDMO from cell line development to GMP manufacturing, formulation, analytics, and fill-finish. [See CDMO profile]
Mabion: Fully integrated clinical CDMO for biotherapeutics, including monoclonal antibodies and recombinant proteins. [See CDMO profile]
Reig Jofre: Production of injectables (lyophilized and liquid) and non-sterile liquids. [See CDMO profile]
VIVEbiotech: GMP CDMO specialized exclusively in lentiviral vectors. [See CDMO profile]
Let MAI CDMO Help You Find the Right Clinical Manufacturing Partner
Navigating the complexities of investigational product development and clinical manufacturing can be challenging. MAI CDMO simplifies the process by connecting you with trusted clinical CDMOs specialized in GMP-compliant clinical trial production.
Our team ensures that your project aligns with the capabilities of leading clinical manufacturing providers, facilitating a seamless path from early-stage development to market approval.
Contact us today to find the best investigational product CDMO and accelerate your clinical manufacturing journey with a reliable partner.